Form 4: Third Harmonic Bio Director's Share Cancellation

A director of Third Harmonic Bio, Inc. reported the cancellation of over 5.7 million shares and stock options in connection with the company's dissolution and a $5.35 per share liquidation distribution.

Summary

• David P. Bonita, a Director and 10% Owner of Third Harmonic Bio, Inc. (THRD), reported changes in his beneficial ownership.
• The reported changes are directly linked to the dissolution of Third Harmonic Bio, Inc.
• 5,779,071 shares of common stock held by the reporting person were cancelled.
• 43,584 stock options held by the reporting person were also cancelled.
• A liquidation distribution of $5.35 per share of Common Stock was received by the reporting person.
• For stock options, the liquidation distribution received was $5.35 per share less the exercise price of such options.

Sentiment

Score: 2

Explanation: The filing indicates the dissolution of the company, which is a highly negative event for shareholders, despite a liquidation distribution. It signifies the end of the investment.

Negatives

• Third Harmonic Bio, Inc. is undergoing dissolution, indicating the cessation of its operations as a going concern.
• The cancellation of all common stock and stock options held by the reporting person signifies the complete liquidation of their equity stake in the company.

Risks

• The company's dissolution means there is no future operational upside or potential for share price appreciation.
• Shareholders are receiving a final liquidation distribution, which may or may not fully compensate for their initial investment or potential future value.

Future Outlook

The company is dissolving, indicating the cessation of all future operations and business activities. The outlook is limited to the final liquidation process.

Management Comments

• Transaction reported is a cancellation of shares of common stock in connection with the dissolution of the Issuer.
• The reporting person received a liquidation distribution of $5.35 per share of Common Stock from Issuer.
• Represents payment of the liquidation distribution of $5.35 per share less the exercise price of such options.

Industry Context

This filing indicates the complete cessation of operations for Third Harmonic Bio, Inc. It does not provide broader industry trends but rather a specific company's exit from the market. For the biotech/pharma industry, company dissolutions can occur due to failed clinical trials, lack of funding, or strategic decisions to return capital to shareholders.

Stakeholder Impact

• Shareholders: Will receive a final liquidation distribution of $5.35 per share, but the company will cease to exist, eliminating future investment potential.
• Employees: Likely face job loss due to company dissolution.
• Customers/Suppliers: Will no longer have a relationship with Third Harmonic Bio, Inc. as it dissolves.

Key Dates

Recommendation

The company, Third Harmonic Bio, Inc., is undergoing dissolution, meaning it will cease operations and its shares will no longer trade. The filing details the cancellation of shares and options in exchange for a final liquidation distribution. There is no future business to invest in, making a 'sell' or 'liquidate' recommendation appropriate for any remaining holdings.

Keywords

Third Harmonic Bio, THRD, SEC Form 4, Beneficial Ownership, Company Dissolution, Liquidation Distribution, Share Cancellation, Stock Options, David P. Bonita